Bevacizumab/high-dose chemotherapy with autologous stem-cell transplant for poor-risk relapsed or refractory germ-cell tumors [Ann Oncol, 26, (2015), 2125-2132] doi: 10.1093/annonc/mdv310

Y. Nieto; S. M. Tu; R. Bassett; R. B. Jones; A. M. Gulbis; N. Tannir; A. Kingham; C. Ledesma; K. Margolin; L. Holmberg; R. Champlin; L. Pagliaro

doi:10.1093/annonc/mdv479

Bevacizumab/high-dose chemotherapy with autologous stem-cell transplant for poor-risk relapsed or refractory germ-cell tumors [Ann Oncol, 26, (2015), 2125-2132] doi: 10.1093/annonc/mdv310

Y. Nieto, S. M. Tu, R. Bassett, R. B. Jones, A. M. Gulbis, N. Tannir, A. Kingham, C. Ledesma, K. Margolin, L. Holmberg, R. Champlin, L. Pagliaro

Research output: Contribution to journal › Comment/debate

5 Scopus citations

Original language	English
Pages (from-to)	2507-2508
Number of pages	2
Journal	Annals of Oncology
Volume	26
Issue number	12
DOIs	https://doi.org/10.1093/annonc/mdv479
State	Published - Dec 1 2015

Access to Document

10.1093/annonc/mdv479

Cite this

Nieto, Y., Tu, S. M., Bassett, R., Jones, R. B., Gulbis, A. M., Tannir, N., Kingham, A., Ledesma, C., Margolin, K., Holmberg, L., Champlin, R., & Pagliaro, L. (2015). Bevacizumab/high-dose chemotherapy with autologous stem-cell transplant for poor-risk relapsed or refractory germ-cell tumors [Ann Oncol, 26, (2015), 2125-2132] doi: 10.1093/annonc/mdv310. Annals of Oncology, 26(12), 2507-2508. https://doi.org/10.1093/annonc/mdv479

@article{db955dadc24842d59e342c918961ccbe,

title = "Bevacizumab/high-dose chemotherapy with autologous stem-cell transplant for poor-risk relapsed or refractory germ-cell tumors [Ann Oncol, 26, (2015), 2125-2132] doi: 10.1093/annonc/mdv310",

author = "Y. Nieto and Tu, {S. M.} and R. Bassett and Jones, {R. B.} and Gulbis, {A. M.} and N. Tannir and A. Kingham and C. Ledesma and K. Margolin and L. Holmberg and R. Champlin and L. Pagliaro",

year = "2015",

month = dec,

day = "1",

doi = "10.1093/annonc/mdv479",

language = "English",

volume = "26",

pages = "2507--2508",

journal = "Annals of Oncology",

issn = "0923-7534",

publisher = "Elsevier Ltd.",

number = "12",

}

Nieto, Y, Tu, SM, Bassett, R, Jones, RB, Gulbis, AM, Tannir, N, Kingham, A, Ledesma, C, Margolin, K, Holmberg, L, Champlin, R & Pagliaro, L 2015, 'Bevacizumab/high-dose chemotherapy with autologous stem-cell transplant for poor-risk relapsed or refractory germ-cell tumors [Ann Oncol, 26, (2015), 2125-2132] doi: 10.1093/annonc/mdv310', Annals of Oncology, vol. 26, no. 12, pp. 2507-2508. https://doi.org/10.1093/annonc/mdv479

TY - JOUR

T1 - Bevacizumab/high-dose chemotherapy with autologous stem-cell transplant for poor-risk relapsed or refractory germ-cell tumors [Ann Oncol, 26, (2015), 2125-2132] doi

T2 - 10.1093/annonc/mdv310

AU - Nieto, Y.

AU - Tu, S. M.

AU - Bassett, R.

AU - Jones, R. B.

AU - Gulbis, A. M.

AU - Tannir, N.

AU - Kingham, A.

AU - Ledesma, C.

AU - Margolin, K.

AU - Holmberg, L.

AU - Champlin, R.

AU - Pagliaro, L.

PY - 2015/12/1

Y1 - 2015/12/1

UR - http://www.scopus.com/inward/record.url?scp=84949944812&partnerID=8YFLogxK

U2 - 10.1093/annonc/mdv479

DO - 10.1093/annonc/mdv479

M3 - Comment/debate

C2 - 26487577

AN - SCOPUS:84949944812

SN - 0923-7534

VL - 26

SP - 2507

EP - 2508

JO - Annals of Oncology

JF - Annals of Oncology

IS - 12

ER -

Bevacizumab/high-dose chemotherapy with autologous stem-cell transplant for poor-risk relapsed or refractory germ-cell tumors [Ann Oncol, 26, (2015), 2125-2132] doi: 10.1093/annonc/mdv310

Access to Document

Other files and links

Cite this